Rupatadine
Rupatadine, the active substance of Rupiron, is an antihistamine.
Rupiron relieves the symptoms of allergic rhinitis, such as sneezing,
runny nose, itchy eyes and nose.
Rupiron is also used to relieve the symptoms of urticaria
(allergic skin rash), such as itching and rash (local redness and swelling of the skin).
Before taking Rupiron, discuss with your doctor or pharmacist:
Rupiron is not intended for use in children under 12 years of age.
Tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, as well as any medicines you plan to take.
Do not take Rupiron with grapefruit juice and grapefruits,
as it may increase the level of Rupiron in the body.
Rupiron 10 mg does not increase the sedative effect of alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Rupiron is not expected to affect the ability to drive or use machines. However, if you are taking Rupiron for the first time, be cautious and observe your reaction to the medicine before driving or using machines.
This medicine contains 55 mg of lactose (as monohydrate). If you have been diagnosed with an intolerance to some sugars, consult your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Rupiron is intended for use in adolescents (12 years and older) and adults. The recommended dose is one tablet (10 mg rupatadine) once a day with or without food. Swallow the tablet with a sufficient amount of liquid (e.g., a glass of water).
Your doctor will tell you how long to take Rupiron.
If you accidentally take a large dose, contact your doctor or pharmacist immediately.
Take the missed dose as soon as possible, then continue taking the tablets as recommended. Do not take a double dose to make up for the missed dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Rupiron can cause side effects, although not everybody gets them.
Rarely (may affect up to 1 in 1,000 people):
Other side effects include:
Commonly (may affect up to 1 in 10 people):
Uncommonly (may affect up to 1 in 100 people):
Rarely (may affect up to 1 in 1,000 people):
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301,
fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date stated on the carton and blister.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Rupiron tablets are round (6.5 mm in diameter), flat tablets, light orange in color, with "R10" engraved on one side.
The tablets are packaged in blisters, in packs of 15 or 30 tablets.
Not all pack sizes may be marketed.
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
Laboratoris Normon S.A.
Ronda de Valdecarrizo 6
28760 Tres Cantos, Madrid
Spain
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Date of last revision of the leaflet:17.10.2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.